Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × Drug Therapy × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 140 Lung Neoplasms 55 Small Cell Lung Carcinoma 22 Neoplasms 9 NSCLC 8 Mesothelioma, Malignant 8 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Stomach Neoplasms 3 Brain Neoplasms 3 Adenocarcinoma of Lung 3 Thymoma 2 Small Cell Lung Cancer Limited Stage 2 Sarcoma 2 Pleural Effusion, Malignant 2 NSCLC Stage IV Without EGFR/ALK Mutation 2 Mesothelioma 2 Liver Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Extensive Stage Small Cell Lung Cancer 2 Cholangiocarcinoma 2 Carcinoma 2

Interventions

pembrolizumab 2 sintilimab 1 pemigatinib 1 osimertinib 1 durvalumab 1 Vinorelbine 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03351361 2023-03-01

eNERGY

Rennes University Hospital

Phase 3 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡